Mufson EJ - Search Results

1

Prefibrillar tau oligomers in mild cognitive impairment and Alzheimer's disease.

Mufson EJ, Ward S, Binder L. Mufson EJ, et al. Neurodegener Dis. 2014;13(2-3):151-3. doi: 10.1159/000353687. Epub 2013 Sep 11. Neurodegener Dis. 2014. PMID: 24029627 Free PMC article.

2

Apolipoprotein E immunoreactivity within neurofibrillary tangles: relationship to Tau and PHF in Alzheimer's disease.

Benzing WC, Mufson EJ. Benzing WC, et al. Among authors: mufson ej. Exp Neurol. 1995 Apr;132(2):162-71. doi: 10.1016/0014-4886(95)90021-7. Exp Neurol. 1995. PMID: 7540552

3

Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease.

Mufson EJ, Ma SY, Cochran EJ, Bennett DA, Beckett LA, Jaffar S, Saragovi HU, Kordower JH. Mufson EJ, et al. J Comp Neurol. 2000 Nov 6;427(1):19-30. doi: 10.1002/1096-9861(20001106)427:1<19::aid-cne2>3.0.co;2-a. J Comp Neurol. 2000. PMID: 11042589

4

Tau-66: evidence for a novel tau conformation in Alzheimer's disease.

Ghoshal N, García-Sierra F, Fu Y, Beckett LA, Mufson EJ, Kuret J, Berry RW, Binder LI. Ghoshal N, et al. Among authors: mufson ej. J Neurochem. 2001 Jun;77(5):1372-85. doi: 10.1046/j.1471-4159.2001.00346.x. J Neurochem. 2001. PMID: 11389188 Free article.

5

Down-regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease.

Chu Y, Cochran EJ, Bennett DA, Mufson EJ, Kordower JH. Chu Y, et al. Among authors: mufson ej. J Comp Neurol. 2001 Aug 27;437(3):296-307. doi: 10.1002/cne.1284. J Comp Neurol. 2001. PMID: 11494257

6

Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease.

Mufson EJ, Ma SY, Dills J, Cochran EJ, Leurgans S, Wuu J, Bennett DA, Jaffar S, Gilmor ML, Levey AI, Kordower JH. Mufson EJ, et al. J Comp Neurol. 2002 Feb 4;443(2):136-53. doi: 10.1002/cne.10122. J Comp Neurol. 2002. PMID: 11793352

7

Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease.

Mufson EJ, Ikonomovic MD, Styren SD, Counts SE, Wuu J, Leurgans S, Bennett DA, Cochran EJ, DeKosky ST. Mufson EJ, et al. Arch Neurol. 2003 Aug;60(8):1143-8. doi: 10.1001/archneur.60.8.1143. Arch Neurol. 2003. PMID: 12925373

8

Galanin in Alzheimer disease.

Counts SE, Perez SE, Ginsberg SD, De Lacalle S, Mufson EJ. Counts SE, et al. Among authors: mufson ej. Mol Interv. 2003 May;3(3):137-56. doi: 10.1124/mi.3.3.137. Mol Interv. 2003. PMID: 14993421 Review.

9

Galanin plasticity in the cholinergic basal forebrain in Alzheimer's disease and transgenic mice.

Mufson EJ, Counts SE, Perez SE, Binder L. Mufson EJ, et al. Neuropeptides. 2005 Jun;39(3):233-7. doi: 10.1016/j.npep.2004.12.005. Epub 2005 Feb 1. Neuropeptides. 2005. PMID: 15893372 Review.

10

Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment.

Counts SE, Nadeem M, Lad SP, Wuu J, Mufson EJ. Counts SE, et al. Among authors: mufson ej. J Neuropathol Exp Neurol. 2006 Jun;65(6):592-601. doi: 10.1097/00005072-200606000-00007. J Neuropathol Exp Neurol. 2006. PMID: 16783169

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters